Key result
Omapatrilat and captopril prevented mortality and induced complete regression of renal injury in nitric oxide-deficient rats on a normal-sodium diet.
Why the study?
Does omapatrilat induce better regression of renal injury than captopril in nitric oxide-deficient rats on normal or high sodium diets?
Does omapatrilat induce better regression of renal injury than captopril in nitric oxide-deficient rats on normal or high sodium diets?
ACE and vasopeptidase inhibitors exhibit marked renoprotective and antihypertensive effects in nitric oxide-deficient rats on a normal sodium diet, but efficacy is blunted by a high sodium diet.
Answers are grounded in this paper and cite their sources.
ACE/vasopeptidase inhibitors show renoprotective potential in this rat model; hypothesis-generating for human renal disease and blunted by high sodium.
Inhibition of nitric oxide synthases causes systemic hypertension and renal injury in rats. Our objective was to examine whether omapatrilat, a vasopeptidase inhibitor that inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase, could induce better regression of renal injury than ACE inhibitor alone. Ten groups of rats were studied. They were fed either a normal (0.8% NaCl) or a high (4% NaCl) sodium diet. Eight of these groups received NG-nitro-L-arginine methyl ester (L-NAME, 20 mg x kg(-1) x d(-1)) in their drinking water. After 4 weeks, 1 group on each diet was killed and considered the L-NAME group, whereas the others received L-NAME alone, captopril (200 mg x kg(-1) x d(-1)) plus L-NAME, or omapatrilat (80 mg x kg(-1) x d(-1)) plus L-NAME for 4 additional weeks. In rats receiving L-NAME alone for 8 weeks, the mortality rate was approximately 90%, irrespective of the diet. In contrast, all rats survived in the captopril and the omapatrilat groups. In rats fed a normal-sodium diet, captopril and omapatrilat normalized systolic blood pressure and induced a complete regression of renal injury. Creatinine clearance and proteinuria were also normalized. In the high-sodium-diet groups, both treatments were less efficient: blood pressure remained elevated, and the regression of renal fibrosis was only partial. Although proteinuria decreased significantly with captopril or omapatrilat, creatinine clearance remained lower than in the controls. These results demonstrate that, in nitric oxide-deficient rats fed a normal-sodium diet, ACE and vasopeptidase inhibitors exhibit a marked renoprotective effect, whereas these treatments are less efficient in rats fed a high-sodium diet.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2003) studied Systemic hypertension and renal injury. Omapatrilat vs. Captopril (200 mg x kg(-1) x d(-1)) or L-NAME alone was evaluated on Mortality rate. Omapatrilat and captopril prevented mortality and induced complete regression of renal injury in nitric oxide-deficient rats on a normal-sodium diet.
Synapse has enriched 10 related papers. Consider them for comparative context: